Galactosamine

toll-like receptor 4 ; Mus musculus







51 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33083887 Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell. 2021 Apr 4
2 31868940 Cathelicidin deficiency exacerbates cardiac dysfunction in lipopolysaccharide-induced endotoxaemic mice. 2020 Apr 1
3 31074668 Pretreatment with Salvia miltiorrhiza Polysaccharides Protects from Lipopolysaccharides/d-Galactosamine-Induced Liver Injury in Mice Through Inhibiting TLR4/MyD88 Signaling Pathway. 2019 Aug 1
4 31077206 Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway. 2019 May 10 3
5 31474165 Succinate dehydrogenase inhibitor dimethyl malonate alleviates LPS/d-galactosamine-induced acute hepatic damage in mice. 2019 Nov 1
6 28213269 Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways. 2017 Apr 1
7 28887131 Prostacyclin mimetics afford protection against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. 2017 Nov 1 1
8 28963941 Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways. 2017 Nov 1
9 29057809 Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice. 2017 Oct 18 1
10 27627914 MAPK/AP-1-Targeted Anti-Inflammatory Activities of Xanthium strumarium. 2016 1
11 27670746 Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications. 2016 Sep 27 1
12 27711079 Inactivation of Sirt1 in mouse livers protects against endotoxemic liver injury by acetylating and activating NF-κB. 2016 Oct 6 1
13 25749929 Protective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs. 2015 May 1
14 26459629 Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway. 2015 Nov 1 1
15 26494508 Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling. 2015 Dec 24 2
16 24895481 BRP, a polysaccharide fraction isolated from Boschniakia rossica, protects against galactosamine and lipopolysaccharide induced hepatic failure in mice. 2014 May 1
17 25173984 Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice. 2014 Nov 1
18 25325613 Protective effects of lupeol against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice. 2014 Nov 26 2
19 25382719 Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice. 2014 Nov 26 1
20 22415073 Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. 2012 2
21 22963044 Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis. 2012 Oct 2
22 21835267 Cryptotanshinone inhibits LPS-induced proinflammatory mediators via TLR4 and TAK1 signaling pathway. 2011 Nov 1
23 19818826 Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice. 2010 Jan 4
24 19997066 The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury. 2010 Feb 4
25 19682082 Protective effect of p-methoxyl-diphenyl diselenide in lethal acute liver failure induced by lipopolysaccharide and D-galactosamine in mice. 2009 Dec 3
26 19852690 Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162. 2009 Nov 2
27 18251086 Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice. 2008 Jan 1
28 20157398 Protective effect of decursinol on mouse models of sepsis: enhancement of interleukin-10. 2008 Apr 1
29 17353199 Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. 2007 May 4 2
30 17911593 Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. 2007 Oct 15 1
31 16547261 Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha. 2006 Apr 1 3
32 17151479 Reduced lipopolysaccharide (LPS)-induced nitric oxide production in peritoneal macrophages and inhibited LPS-induced lethal shock in mice by a sugar cane (Saccharum officinarum L.) extract. 2006 Dec 2
33 15850520 [Tumor necrosis factor alpha and enterocyte apoptosis in mice with fulminant hepatic failure]. 2005 Apr 1
34 16051691 The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury. 2005 Aug 4
35 15387909 [The experimental study on the expression of toll-like receptor 2 in fulminant hepatic failure]. 2004 Sep 1
36 15577225 Protective effect of protocatechuic acid isopropyl ester against murine models of sepsis: inhibition of TNF-alpha and nitric oxide production and augmentation of IL-10. 2004 Dec 3
37 12963146 Anti-inflammatory properties of Bridelia ferruginea stem bark. Inhibition of lipopolysaccaride-induced septic shock and vascular permeability. 2003 Oct 1
38 11748185 Biological characterization of lipopolysaccharide from Treponema pectinovorum. 2002 Jan 1
39 11740732 Inflammatory reactions in extraoral tissues in mice after intragingival injection of lipopolysaccharide. 2001 Dec 15 1
40 10498828 Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. 1999 Sep 6
41 9573062 Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. 1998 May 1
42 7806345 Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides. 1995 Jan 1
43 7520172 Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. 1994 Aug 16 1
44 7927709 Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene. 1994 Oct 1
45 8168521 Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms. 1994 Apr 1 2
46 8418160 Nontoxic forms of lipopolysaccharides, poorly cleared in vivo, are present in variable amounts in phenol-extracted endotoxins. 1993 Jan 1
47 1716205 Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance. 1991 Sep 9
48 1934597 Actinomycin D upregulates lipopolysaccharide induction of macrophage procoagulant expression and tumour necrosis factor-alpha production. 1991 Nov 1
49 2037372 Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. 1991 Jun 3
50 2228245 Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. 1990 Nov 1